期刊名称：MELANOMA RESEARCH
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Melanoma Research is a multidisciplinary journal devoted to the rapid communication of results in the field of melanoma. Papers reporting physiological, photobiological, epidemiological, chemical, and pathological investigations as well as clinical studies and results of controlled clinical trials are accepted. The Journal provides an international forum for the dissemination and integration of basic and clinical findings.
Instructions to Authors
Note: These instructions comply with those formulated by the International Committee of Medical Journal Editors. For further details, authors should consult the following article: International Committee of Medical Journal Editors. ‘‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals’’ N Engl J Med 1997;336:309–315. The complete document appears at www.icmje.org.
SCOPE
Melanoma Research is a multidisciplinary journal devoted to the rapid communication of results in the field of melanoma. Papers reporting physiological, epidemiological, chemical, and pathological investigations as well as clinical studies and results of controlled clinical trials are accepted. The Journal provides an international forum for the dissemination and integration of basic and clinical findings.
The journal publishes original research and review articles, short communications, i.e. new findings that merit quick dissemination, and letters to the Editors.
POINTS TO CONSIDER WHEN SUBMITTING YOUR PAPER TO ONE OF OUR JOURNALS
We have prepared a standard covering letter (available from the journal website) to accompany your submission. Whether you use this letter or your own wording, please think carefully about the following points and make the appropriate declarations.
Redundant or duplicate publication
We ask you to confirm that your paper has not been published in its current form or a substantially similar form (in print or electronically, including on a web site), that it has not been accepted for publication elsewhere, and that it is not under consideration by another publication. The International Committee of Medical Journal Editors has provided details of what is and what is not duplicate or redundant publication (http://www.icmje.org). If you are in doubt (particularly in the case of material that you have posted on a web site), we ask you to proceed with your submission but to include a copy of the relevant previously published work or work under consideration by other journals. In your covering letter to the editors, draw attention to any published work that concerns the same patients or subjects as the present paper.
Conflicts of interest
We ask authors to state all possible conflicts of interest, including financial and other relationships. If you are sure that there is no conflict of interest, please state this. You might like to look at an editorial in the British Medical Journal on Beyond conflict of interest (http://bmj.com/cgi/content/short/317/7154/291). Remember that sources of funding should be acknowledged in your paper.
Permissions to reproduce previously published material
We ask you to send us copies of permission to reproduce material (such as illustrations) from the copyright holder. We cannot send your paper to press without these permissions!
Patient consent forms
The protection of a patient's right to privacy is essential. We ask you to send copies of patient consent forms on which patients or other subjects of your experiments clearly grant permission for the publication of photographs or other material that might identify them. If the consent form for your research did not specifically include this, please obtain it or remove the identifying material. A sample patient consent form is available from the Journal’s website if required.
Ethics committee approval
You must state clearly in your submission in the Methods section that you conducted studies on human participants must with the approval of an appropriate named ethics committee. Please also look at the latest version of the Declaration of Helsinki (http://www.wma.net/e/policy/b3.htm). Similarly, you must confirm that experiments involving animals adhered to ethical standards and must state the care of animal and licensing guidelines under which the study was performed.
Authorship
We ask that all authors sign the submission letter. First, we have (rarely) had problems when someone named as an author was not aware of the submission of a paper and, on occasion, did not support the findings published. We therefore ask all authors to confirm that they have read and approved the paper. Second, we ask all authors to confirm that they have met the criteria for authorship as established by the International Committee of Medical Journal Editors, believe that the paper represents honest work, and are able to verify the validity of the results reported. You might also be interested to read the debate on authorship in general in the British Medical Journal’s Authorship collection (http://bmj.com/cgi/collection/authorship). Many of the points covered above are discussed in the New England Journal of Medicine’s collection of papers entitled ’Editorials on Journal Policy’ (http://authors.nejm.org/Misc/Policies.asp).
Compliance with NIH and Other Research Funding Agency Accessibility Requirements
A number of research funding agencies now require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, LWW will identify to the National Library of Medicine (NLM) articles that require deposit and will transmit the post-print of an article based on research funded in whole or in part by the National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, or other funding agencies to PubMed Central. The revised Copyright Transfer Agreement provides the mechanism.
Copyright assignment
Papers are accepted for publication on the understanding that exclusive copyright in the paper is assigned to the Publisher. Authors are asked to sign a copyright assignment form after acceptance of their papers. They may use material from their paper in other works published by them.
Submissions
Authors are strongly encouraged to submit their manuscripts through the web-based tracking system at http://www.editorialmanager.com/mr. Signed author forms may be included in the submission as a 'supporting document' or mailed to the journal office. The site contains instructions and advice on how to use the system. Authors should NOT in addition then post a hard copy submission to the editorial office, unless you are supplying artwork, letters or files that cannot be submitted electronically, or have been instructed to do so by the editorial office. Include the following where appropriate: subject consent forms; transfer of copyright form; permission to reproduce previously published material; checklist. For those authors who have no option but to submit by mail please send one copy of the article, plus an electronic version on disk or CD-ROM to the following address: Melanoma Research, Lippincott Williams & Wilkins, 250 Waterloo Road, London SE1 8RD, UK.
Double spacing should be used throughout the manuscript, which should include the following sections, each starting on a separate page: Title Page, abstract and keywords, text, acknowledgements, references, individual tables and captions. Margins should be not less than 3 cm. Pages should be numbered consecutively, beginning with the Title Page, and the page number should be placed in the top right hand corner of each page. Abbreviations should be defined on their first appearance in the text; those not accepted by international bodies should be avoided.
Authors are invited to list up to four potential reviewers, including their full addresses, telephone and fax numbers, and e-mail addresses.
PRESENTATION OF PAPERS
Title Page
The Title Page should carry the full title of the paper and a short title to be used as a ‘running head’ (and which should be so identified). The first name, middle initial and last name of each author should appear. If the work is to be attributed to a department or institution, its full name should be included. Any disclaimers should appear on the Title Page, as should the name and address of the author responsible for correspondence concerning the manuscript and the name and address of the author to whom requests for reprints should be made. Finally, the Title Page should include the sources of any support for the work in the form of grants, equipment, drugs, or any combination of these. Disclose funding received for this work from any of the following organizations: National Institutes of Health (NIH); Wellcome Trust; Howard Hughes Medical Institute (HHMI); and other(s).
Abstracts
The second page should carry a structured abstract of no more than 250 words. The abstract should state the Objective(s) of the study or investigation, basic Methods (selection of study subjects or laboratory animals; observational and analytical methods), main Results (giving specific data and their statistical significance, if possible), and the principal Conclusions. It should emphasise new and important aspects of the study or observations.
Key Words
The abstract should be followed by a list of 3–10 keywords or short phrases which will assist the cross-indexing of the article and which may be published. When possible, the terms used should be from the Medical Subject Headings list of the Index Medicus (http://www.nlm.nih.gov/mesh/meshhome.html).
Text
Full papers of an experimental or observational nature may be divided into sections headed Introduction, Methods (including ethical and statistical information), Results and Discussion (including a conclusion), although reviews may require a different format.
Acknowledgements
Acknowledgements should be made only to those who have made a substantial contribution to the study. Authors are responsible for obtaining written permission from people acknowledged by name in case readers infer their endorsement of data and conclusions.
References
References should be numbered consecutively in the order in which they first appear in the text. They should be assigned Arabic numerals, which should be given in brackets, e.g. [17]. References should include the names of all authors when six or fewer; when seven or more, list only the first six names and add et al. References should also include full title and source information. Journal names should be abbreviated as in the Index Medicus (http://www.nlm.nih.gov/tsd/serials/terms_cond.html).
Articles in journals
Standard journal article:
Hernberg MM, Hahka-Kemppinen MH, Pyrhonen SO. The prognostic role of CD4+ and CD8+ lymphocytes during chemoimmunotherapy in metastatic melanoma. Melanoma Res 2004; 14: 493-500.
More than six authors:
Kopf AW, Gross DF, Rodgers GS, Rigel DS, Hellman LJ, Levenstein M, et al. Prognostic index for malignant melanoma. Cancer 1987; 59: 1236–1241
Supplements:
Statius Muller MG, Van Leeuwen PA, Borgstein PJ, Pijpers R, Meijer S. The sentinel node procedure in cutaneous melanoma: an overview of 6 years’ experience. Eur J Nucl Med 1999; 26 (suppl): S20–25.
Books
Book:
Hedges LV, Olkin J. Statistical Methods for Meta-Analysis. San Diego: Academic Press, 1985.
Chapter in a book:
Blackshaw AJ. Non-Hodgkin’s lymphomas of the gut. In: Recent Advances in Gastrointestinal Pathology. Wright R (editor). New York: Saunders; 1980. pp. 213–240. Personal communications and unpublished work should not feature in the reference list but should appear in parentheses in the text. Unpublished work accepted for publication but not yet released should be included in the reference list with the words ‘in press’ in parentheses beside the name of the journal concerned. References must be verified by the author(s) against the original documents.
Tables
Each table should be typed on a separate sheet in double spacing. Tables should not be submitted as photographs. Each table should be assigned an Arabic numeral, e.g. (Table 3) and a brief title. Vertical rules should not be used. Place explanatory matter in footnotes, not in the heading. Explain in footnotes all non-standard abbreviations that are used in each table. Identify statistical measures of variations, such as standard deviation and standard error of the mean.
Be sure that each table is cited in the text. If you use data from another published or unpublished source, obtain permission and acknowledge the source fully.
Illustrations
References to figures and tables should be made in order of appearance in the text and should be in Arabic numerals in parentheses, e.g. (Fig. 2). Most file formats are accepted, but TIFF and EPS files, with fonts embedded, are preferred. If scanned, line art should be at a resolution of 800 dpi, and halftones and colour at 300 dpi. All colour values should be CMYK. If hard copies are submitted they should have a label pasted to the back bearing the figure number, the title of the paper, the author’s name and a mark indicating the top of the figure. Illustrations should be presented to a width of 82 mm or, when the illustration demands it, to a width of 166 mm. Photomicrographs must have internal scale markers. If photographs of people are used, their identities must be obscured or the picture must be accompanied by written consent to use the photograph. If a figure has been published before, the original source must be acknowledged and written permission from the copyright holder for both print and electronic formats should be submitted with the material. Permission is required regardless of authorship or publisher, except for documents in the public domain. Figures may be reduced, cropped or deleted at the discretion of the editor. Colour illustrations are acceptable but authors will be expected to cover the extra reproduction costs (for current charges, contact the publisher).
Legends for illustrations
Captions should be typed in double spacing, beginning on a separate sheet of paper. Each one should have an Arabic numeral corresponding to the illustration to which it refers. Internal scales should be explained and staining methods for photomicrographs should be identified.
Units of measurement
Measurements of length, height, weight, and volume should be reported in metric units (metre, kilogram, or litre) or their decimal multiples. Temperatures should be given in degrees Celsius. Blood pressures should be given in millimetres of mercury.
All haematological and clinical chemistry measurements should be reported in the metric system in terms of the International System of Units (SI). Editors may request that alternative or non-SI units be added by the authors before publication.
Abbreviations and symbols
Use only standard abbreviations. Avoid abbreviations in the title and abstract. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement.
Offprints
Offprints may be purchased using the appropriate form that will be made available with proofs. Orders should be sent when the proofs are returned; orders received after this time cannot be fulfilled.
Editorial Board
Executive Editors
Ferdy J. Lejeune
Editor-in-Chief for Clinical Research
Professor Emeritus of Oncology
Division of Experimental Oncology
CePO-University of Lausanne
Chemin du Levant 98
CH-1005 Lausanne
Switzerland
Phone: +41-76 3261806
ferdinand.lejeune@unil.ch W.J. Storkus
Editor for Basic Research
Professor of Dermatology and Immunology
W1041.2 Biomedical Sciences Tower
University of Pittsburgh School of Medicine
200 Lothrop Street
Pittsburgh, PA 15213, USA
Phone: +1 412-648-9981
Fax: +1 412-383-5857
storkuswj@upmc.edu
Associate Editor
C.M. Balch
Baltimore, MD, USA
A. Cochran
Los Angeles, CA, USA
A.M.M. Eggermont
Rotterdam, The Netherlands
S. Ferrone
Pittsburgh, PA, USA
I.J. Fidler
Houston, TX, USA
P.B. Fisher
Richmond, VA, USA M. Gore
London, UK
M. Herlyn
Philadelphia, PA, USA
K. Jimbow
Sapporo, Japan
L.A. Liotta
Manassas, VA, USA
G. Parmiani
Milan, Italy
S. Pavel
Leiden, Netherlands
J. Pawelek
New Haven, CT, USA
Editorial Advisory Board
Philippe Autier
Lyon, France
M.-F. Avril
Paris, France
T. Boon
Brussels, Belgium
E.-B. Bröcker
Würzburg, Germany
N. Cascinelli
Milan, Italy
F. Di Filippo
Rome, Italy
J.-F. Doré
Lyon, France
R. Dummer
Zurich, Switzerland
J.M. Elwood
Melbourne, Australia
V. Englehard
Charlottesville, VA, USA
C. Garbe
Tubingen, Germany
J.-J. Grob
Marseille, France
J.W. Harbour
St Louis, MO, USA
P. Hersey
Newcastle, NSW, Australia
A. Houghton
New York, NY, USA
M. Ichihashi
Kobe, Japan
S. Ito
Aichi, Japan
U. Keilholz
Berlin, Germany
D. Khayat
Paris, France
J.M. Kirkwood
Pittsburgh, PA, USA
F.L. Meyskens
Los Angeles, CA, USA
M.C. Mihm
Boston, MA, USA
D. Morton
Los Angles, CA, USA
J. Nakayama
Fukuoka, Japan
J Newton Bishop
Leeds, UK
H. Pehamberger
Vienna, Austria
C.R. Rossi
Padova, Italy
D. Schadendorf
Gebaeude, Germany
A. Sober
Boston, NA, USA
A. Spatz
Montreal, Canada
A. Taieb
Bordeaux, France
A. Testori
Milan, Italy
|
